Stratview Research delivers key insights into the global Neurodegenerative Drugs Market. According to Stratview Research, the market is segmented By Type (N-Methyl-D-Aspartic Acid (NMDA), Selective Serotonin Reuptake Inhibitors (SSRIs), Dopamine Inhibitors, Other), Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), and Region - COVID-19 Impact Analysis and Forecast to 2026.
According to the report, The Neurodegenerative Drugs Market is projected to grow from USD 39.1 billion in 2020 to USD 58.3 billion by 2026 at a CAGR of around 7.0% during the forecast period.
Wish to know more about the study? Click here to get a free sample.
- Novartis International AG (Switzerland)
- Pfizer Inc. (US)
- Merck Serono (Germany)
- Biogen Inc. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Benetton Group S.r.l. (Italy)
- C.H. Boehringer Sohn AG & Ko. KG (Germany)
- Sanofi S.A. (France)
- GlaxoSmithKline plc (UK).
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing & procurement, target screening, and others, please send your inquiry to firstname.lastname@example.org
What we do-
Stratview Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients existing globally. We at Stratview Research are obliged to serve our diverse customer base present across the industries of Aerospace, Oil and Gas, Automotive, and Chemicals, etc. among various other industries present around the world. We strive to provide our customers with updated information on ground-breaking technologies, high growing markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.